January 2024

Civica by the Numbers

Delivering vital medications

vials or syringes
of essential
generic medications
to treat over

Solving critical drug shortages

from Civica

Building innovative partnerships

Health System Members
Manufacturing Partners

January 1, 2024

Becker’s Healthcare Podcast Featuring Civica Board Chairman Dan Liljenquist

Recorded live at the 11th Annual Becker’s Healthcare CEO + CFO Roundtable, Dan Liljenquist, Chief Strategy Officer at Intermountain Healthcare and Board Chair at Civica Rx, discussed the issues around increased denials, the shifting regulatory landscape and more.

January 31, 2024

Podnosis: Catching up with the Fierce 15 of 2019

This episode of “Podnosis” rewinds to January 2019 when Fierce Healthcare unveiled its inaugural Fierce 15, spotlighting 15 private companies engaged in pioneering work and making waves in healthcare innovation. Hear from Civica Rx CEO Ned McCoy about Civica Rx’s journey.

February 6, 2024

Civica’s Allan Coukell Talks about Drug Shortages at a 2024 US House Committee on Ways and Means Hearing

View video excerpts from the U.S. House Committee on Ways & Means hearing on drug shortages, including Civica Rx’s Allan Coukell’s opening comments and responses to numerous questions from members of the Committee. Participants discussed drug shortages for four hours, addressing causes of shortages, potential policy-related solutions and the overall impact on patients.

Media Coverage

Six Key Moments from Hearing on Chronic Drug Shortages
Civica Allan Coukell Testimony, Ways and Means

February 6, 2024

Podcast: How Hospitals are Helping Tackle the Drug Shortage Crisis

Hear from Civica’s Chief Government Affairs and Public Policy Officer Allan Coukell about the state of hospital drug shortages in the U.S. today and how Civica’s non-profit model and policy solutions are tackling the issues and bringing stability to the market.

March 4, 2024

CivicaScript: Using the Healthcare Utility Model to Manage Pharmacy Cost for Patients and Payers

CivicaScript, along with members Blue Shield of California and Lumicera Health Services, is featured in Managed Healthcare Executive, showcasing the good that can happen when innovative, like-minded stakeholders work together to make generic medicines affordable and accessible to patients.

Media Coverage

Using the Healthcare Utility Model to Manage Pharmacy Cost for Patients and Payers

March 22, 2024

Case Study – Civica, groninger and SKAN Partnering on Essential Medicines

Civica is the only pharmaceutical company created for the express purpose of preventing and mitigating drug shortages. We partnered with experienced market leaders groninger and SKAN to technologically equip our new Virginia facility. Learn more about our inspiring collaboration in this video.

April 25, 2024

Harvard Business Review: A Proven Model to Combat US Drug Shortages

Drug shortages have been a chronic problem in the U.S. for well over a decade. Today, drug shortages are at a record high with over 300 essential generic medications in short supply.

The “Civica model” is different from the traditional generic drug supply chain and could inspire improvements to the larger U.S. system.

Media Coverage

A Proven Model to Combat U.S. Drug Shortages

May 22, 2024

Podnosis: Hospitals Grapple with Generic Drug Supply Shortages

Civica Chief Government Affairs and Public Policy Officer Allan Coukell discusses how the Civica business model addresses drug shortages within hospitals, allowing them to serve patients more effectively, and how eliminating shortages reduces costs within hospitals.

May 28, 2024

Civica’s New High-value Filling Lines Produce Insulin and More

Civica is on a mission to deliver quality generic medicines – including insulin – at low cost. A new isolator-integrated vial filling line and nest filling line allow them to produce many different forms of injectables and to pivot based on greatest need.

Media Coverage

Nonprofit Civica’s New High-value Filling Lines Produce Insulin and More

June 5, 2024

Drug Shortages are Lasting Longer, Driven by Economic Pressures

A U.S. Pharmacopeia report offers insight into the economic issues surrounding the record high number of drug shortages and efforts to combat the shortages.

Media Coverage

Drug Shortages Lasting Longer, Driven by Economic Factors: US Pharmacopeia Report

Stay tuned!

The members section is currently being built, based on feedback from users like yourself.


Not a member yet? Get information on joining here.